Skip to search formSkip to main contentSkip to account menu

Vaqta

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
IntroductionThis randomised, observer-blind clinical trial conducted in Turkey evaluated the immunogenicity, safety and… 
2006
2006
Background: The objective of this study is to assess whether hepatitis A vaccine is immunogenic and well tolerated when… 
2004
2004
In Jiangsu, 30% of children between the ages of 5 and 8 years test seropositive for hepatitis A. The safety, tolerability, and… 
2003
2003
Cultivation of MRC‐5 cells and attenuated hepatitis A virus (HAV) for the production of VAQTA, an inactivated HAV vaccine ( 1… 
1997
1997
Solvent extraction is a very powerful purification step in the preparation of VAQTA, a highly purified, inactivated hepatitis A… 
Highly Cited
1996
Highly Cited
1996
Recent papers examining the expected persistence of anti‐hepatitis A virus antibody following vaccination with inactivated… 
1996
1996
The development of the purification process for VAQTA, which results in a highly purified inactivated hepatitis A vaccine, was… 
1995
1995
The safety/tolerability profile, immunogenicity and protective efficacy of VAQTA, Merck's hepatitis A vaccine, purified…